Skip to main content
SpringerLink
Log in

Glaucoma Medications’ Effect on Ocular Surface

  • Chapter
  • First Online:
Biophysical Properties in Glaucoma

  • 448 Accesses

Abstract

Finding a perfect topical drug for glaucoma patients can be a challenging task. A perfect drug must not only be sufficiently effective, but also tolerated well by the patient. Evaluating antiglaucomatous drugs’ effects to ocular surface, three major factors must be considered: ocular surface toxicity, inflammation and allergy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Lee SY, Lee H, Bae HW, Kim T-i, Kim CY. Tear lipid layer thickness change and topical anti-glaucoma medication use. Optom Vis Sci. 2016;93(10):1210–7. https://doi.org/10.1097/OPX.0000000000000943.

    Article  PubMed  Google Scholar 

  2. Whitson JT, Trattler WB, Matossian C, Williams J, Hollander DA. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension. J Ocul Pharmacol Ther. 2010;26(3):287–92. https://doi.org/10.1089/jop.2009.0134.

    Article  CAS  PubMed  Google Scholar 

  3. Lin L, Zhao YJ, Chew PTK, Sng CCA, Wong H-T, Yip LW, Tuck Seng W, et al. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension. Ann Pharmacother. 2014;48(12):1585–93. https://doi.org/10.1177/1060028014548569.

    Article  CAS  PubMed  Google Scholar 

  4. Mishra D, Sinha BP, Kumar MS. Comparing the efficacy of Latanoprost (0.005%), Bimatoprost (0.03%), Travoprost (0.004%), and Timolol (0.5%) in the treatment of primary open angle glaucoma. Korean J Ophthalmol. 2014;28(5):399–407. https://doi.org/10.3341/kjo.2014.28.5.399.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Figus M, Nardi M, Piaggi P, Sartini M, Guidi G, Martini L, Lazzeri S. Bimatoprost 0.01% vs Bimatoprost 0.03%: a 12-month prospective trial of clinical and in vivo confocal microscopy in glaucoma patients. Eye (Basingstoke). 2014;28(4):422–9. https://doi.org/10.1038/eye.2013.304.

    Article  CAS  Google Scholar 

  6. Chen J, Dinh T, Woodward DF, Holland M, Yuan Y-D, Lin T-H, Wheeler L a. Bimatoprost: mechanism of ocular surface hyperemia associated with topical therapy. Cardiovasc Drug Rev. 2005;23(3):231–46.

    Article  CAS  Google Scholar 

  7. Schrems WA, Schrems-Hoesl LM, Mardin CY, Horn FK, Juenemann AGM, Kruse FE, Braun JM, Laemmer R. The effect of long-term Antiglaucomatous drug administration on central corneal thickness. J Glaucoma. 2016;25(3):274–80. https://doi.org/10.1097/IJG.0000000000000190.

    Article  PubMed  Google Scholar 

  8. Asbell PA, Potapova N. Effects of topical Antiglaucoma medications on the ocular surface. Ocul Surf. 2005;3(1):27–40. https://doi.org/10.1016/S1542-0124(12)70120-9.

    Article  PubMed  Google Scholar 

  9. Servat JJ, Bernardino CR. Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue. Drugs Aging. 2011;28(4):267–82. https://doi.org/10.2165/11588830-000000000-00000.

    Article  CAS  PubMed  Google Scholar 

  10. Trocme S, Hwang LJ, Bean GW, Sultan MB. The role of Benzalkonium chloride in the occurrence of punctate keratitis: a meta-analysis of randomized, controlled clinical trials. Ann Pharmacother. 2010;44(12):1914–21. https://doi.org/10.1345/aph.1P268.

    Article  CAS  PubMed  Google Scholar 

  11. Weissman SS, Asbell PA. Effects of topical Timolol (0.5%) and Betaxolol (0.5%) on corneal sensitivity. Br J Ophthalmol. 1990;74(7):409–12. http://www.ncbi.nlm.nih.gov/pubmed/2378856

    Article  CAS  Google Scholar 

  12. Zhao JC, Chen T. Brinzolamide induced reversible corneal Decompensation. Br J Ophthalmol. 2005;89(3):389–90. https://doi.org/10.1136/bjo.2004.049544.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Mantelli F, Abdolrahimzadeh S, Mannino G, Lambiase A. Unusual case of angle closure Glaucoma in a patient with Neurofibromatosis type 1. Case Rep Ophthalmol. 2014;5(3):386–91. https://doi.org/10.1159/000369334.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Osborne SA, Montgomery DMI, Morris D, McKay IC. Alphagan allergy may increase the propensity for multiple eye-drop allergy. Eye. 2005;19(2):129–37. https://doi.org/10.1038/sj.eye.6701441.

    Article  CAS  PubMed  Google Scholar 

  15. Manni G, Centofanti M, Sacchetti M, Oddone F, Bonini S, Parravano M, Bucci MG. Demographic and clinical factors associated with development of Brimonidine tartrate 0.2%-induced ocular allergy. J Glaucoma. 2004;13(2):163–7. http://www.ncbi.nlm.nih.gov/pubmed/15097264

    Article  Google Scholar 

  16. Carrasco MA, Schlaen BA, Zárate JO. Brimonidine–timolol fixed combination induced granulomatous inflammation of the eye. Int Ophthalmol. 2013;33(5):557–60. https://doi.org/10.1007/s10792-012-9688-0.

    Article  PubMed  Google Scholar 

  17. Byles DB, Frith P, Salmon JF. Anterior uveitis as a side effect of topical Brimonidine. Am J Ophthalmol. 2000;130(3):287–91. http://www.ncbi.nlm.nih.gov/pubmed/11020406

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lithuanian University of Health Science, Kaunas, Lithuania

    Giedre Pakuliene

Authors
  1. Giedre Pakuliene
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Lithuanian University of Health Sciences, Kaunas, Lithuania

    Ingrida Januleviciene

  2. Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, IN, USA

    Alon Harris

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pakuliene, G. (2019). Glaucoma Medications’ Effect on Ocular Surface. In: Januleviciene, I., Harris, A. (eds) Biophysical Properties in Glaucoma. Springer, Cham. https://doi.org/10.1007/978-3-319-98198-7_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-98198-7_23

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-98197-0

  • Online ISBN: 978-3-319-98198-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation